1 / 10

Nuclear Medicine Market 2018 | Emerging Trends | Key Players

Radiopharmaceuticals is a medical specialty that uses specific radiotracers, and have emerged as an efficient imaging technology in the field of nuclear medicine. The non-invasive nature of radiopharmaceuticals has quickened the diagnosis of various diseases such as cardiovascular diseases, neurological disorders, and cancers.

Abhi711
Download Presentation

Nuclear Medicine Market 2018 | Emerging Trends | Key Players

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nuclear Medicine Market Global Opportunity Analysis and Industry Forecast, 2014 - 2022

  2. Introduction • Global Nuclear Medicine Market is expected to garner $8,207.5 million by 2022. The market is currently in its growth stage driven by increasing number of cancer cases and rising awareness about nuclear medicine. Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance that is used in the treatment of cancer and cardiac & neurological disorders. • The conventional chemotherapy methods are being replaced by more convenient therapeutic radiopharmaceuticals for oncology and cancer treatment, which opens up new avenues in the radiopharmaceuticals market. Moreover, it not only helps physicians during diagnosis, but also works as a convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices.

  3. Nuclear Medicine Market Scopeof theReport KeyBenefits KeyAudiences

  4. Key Benefits • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global nuclear medicine market. • This report includes a detailed quantitative analysis of the current market and estimations from 2014 to 2022, which contribute in identifying the key market opportunities for growth. • Exhaustive analysis of the global radiopharmaceuticals market by type helps in understanding the types of radiopharmaceuticals that are currently being used along with the variants that would gain prominence in the future. • Competitive intelligence (of leading manufacturers of radiopharmaceuticals) helps in understanding the competitive scenario across the geographies. • Key market players within the radiopharmaceuticals market are profiled in this report and their strategies are analyzed thoroughly. This helps in understanding the competitive outlook of the global nuclear medicine market.

  5. Table of Content (TOC) Chapter: 1 Introduction Chapter: 2 Executive Summary Chapter: 3 Market Overview Chapter: 4 World Radiopharmaceuticals Market, By Type, 2014-2022 Chapter: 5 World Radiopharmaceuticals Market, By Modality, 2014-2022 Chapter: 6 World Radiopharmaceuticals Market, By Application, 2014-2022 Chapter: 7 World Radiopharmaceuticals Market, By End-user, 2014-2022 Chapter: 8 World Radiopharmaceuticals Market, By Geography, 2014-2022 Chapter: 9 Company Profiles

  6. Segments

  7. Segments

  8. Analyst Review • Radiopharmaceuticals is a medical specialty that uses specific radiotracers, and have emerged as an efficient imaging technology in the field of nuclear medicine. The non-invasive nature of radiopharmaceuticals has quickened the diagnosis of various diseases such as cardiovascular diseases, neurological disorders, and cancers. Nowadays, therapeutic radiopharmaceuticals are preferred to conventional therapeutic modalities, such as chemotherapy, in the field of oncology for treating cancers. Radiopharmaceuticals are mostly used in diagnostic applications due to advancements in the field such as hybrid imaging technologies using PET/CT and SPECT/CT. • Convenient therapeutic radiopharmaceuticals procedures have a higher capability of mapping physiological functions and metabolic activities and providing specific information about organ function and dysfunction as compared to conventional imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasonography (US) among others. Furthermore, increase in incidence of cancer & cardiovascular aliments, growing demand for alpha radio immunotherapy-based targeted cancer treatment, need for nuclear imaging techniques, and advancements in radiotracers have opened new avenues for radiopharmaceutical manufactures.

  9. Company Profiles • Mallinckrodt plc. • General Electric Co. • Medtronic, plc. (Covidien, acquired by Medtronic) • Bayer AG • Cardinal Health, Inc. • Lantheus Medical Imaging, Inc.

  10. Thank You ThankYou! For MoreDetails Do Enquiry https://www.alliedmarketresearch.com/nuclear-medicine-radiopharmaceuticals-market Follow UsOn

More Related